Companies / Industrials
DOV
Dover Corporation
Industrial Machinery & Supplies & Components
Industrial Machinery & Supplies & ComponentsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health62
Growth34
Profitability56
Cash generation70
Balance sheet70
Dilution control82
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)7.5%Revenue growth (FY)4.5%Revenue CAGR (3y)1.0%Gross margin39.8%Operating margin17.0%Net margin13.5%Free cash flow margin13.8%R&D / revenue2.0%Stock comp / revenue0.5%Net debt / operating cash flow2.29xCurrent ratio1.79Diluted share count change-0.7%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $7.9B | $7.8B | $7.7B | $7.7B | $8.1B |
| Gross profit | $3.0B | $2.9B | $2.9B | $3.0B | $3.2B |
| Operating income | $1.3B | $1.3B | $1.2B | $1.2B | $1.4B |
| Net income | $1.1B | $1.1B | $1.1B | $2.7B | $1.1B |
| Operating cash flow | $1.1B | $806M | $1.3B | $1.1B | $1.3B |
| Capital expenditure | $171M | $211M | $183M | $168M | $220M |
| Free cash flow | $944M | $595M | $1.2B | $920M | $1.1B |
| R&D | $158M | $151M | $139M | $150M | $165M |
| Stock-based comp | $31M | $30M | $31M | $40M | $44M |
| Buybacks | $22M | $585M | $0 | $500M | $541M |
| Dividends | $287M | $288M | $284M | $283M | $283M |
| Cash | $386M | $381M | $399M | $1.8B | $1.7B |
| Total debt | $3.1B | $4.4B | $3.5B | $3.7B | $4.7B |
| Equity | $4.2B | $4.3B | $5.1B | $7.0B | $7.4B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.